Harbor Health Care ETF MEDI
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.80%
- Net assets
- $41.2M
- Holdings
- 44
- 12-month distribution yield
- 0.23%
- Asset class
- Equity
Harbor Health Care ETF (MEDI) is an exchange-traded fund listed on NYSE Arca in the United States, issued by Harbor. Its category is Equity · Global (equity). Its last price was US$32.58 on 20 Oct 2026. Its expense ratio is 0.8% a year, from its prospectus dated 1 Mar 2026. It reported net assets of US$41.21 million as of 31 Jul 2026. Its latest holdings report lists 44 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.0750 a unit, a 12-month distribution yield of 0.23%, paid yearly.
Fees
- Total annual operating expenses (gross)
- 0.80%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.80%
- Prospectus date
- 1 Mar 2026
- Filed with the SEC
- 27 Feb 2026
Size and reporting
- Net assets
- $41,207,807
- Total assets
- $41,237,032
- Holdings as of
- 31 Jul 2026
- Report made public
- 25 Sep 2026 (56 days after the month end)
Top holdings
Largest 25 of 44 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 20.78% | $8.6M | Equity (common) | United States | USD |
| 2 | Ascendis Pharma A/S | DK0060615755 | 13.61% | $5.6M | Equity (common) | Denmark | USD |
| 3 | Gilead Sciences Inc | US3755581036 | 5.10% | $2.1M | Equity (common) | United States | USD |
| 4 | Rhythm Pharmaceuticals Inc | US76243J1051 | 4.02% | $1.7M | Equity (common) | United States | USD |
| 5 | AbbVie Inc | US00287Y1091 | 3.09% | $1.3M | Equity (common) | United States | USD |
| 6 | Intuitive Surgical Inc | US46120E6023 | 2.83% | $1.2M | Equity (common) | United States | USD |
| 7 | Cencora Inc | US03073E1055 | 2.75% | $1.1M | Equity (common) | United States | USD |
| 8 | Revolution Medicines Inc | US76155X1000 | 2.54% | $1.0M | Equity (common) | United States | USD |
| 9 | Insmed Inc | US4576693075 | 2.52% | $1.0M | Equity (common) | United States | USD |
| 10 | Merck & Co Inc | US58933Y1055 | 2.47% | $1.0M | Equity (common) | United States | USD |
| 11 | Boston Scientific Corp | US1011371077 | 2.40% | $989K | Equity (common) | United States | USD |
| 12 | Natera Inc | US6323071042 | 2.26% | $930K | Equity (common) | United States | USD |
| 13 | Abivax SA | US00370M1036 | 2.16% | $892K | Equity (common) | France | USD |
| 14 | Insulet Corp | US45784P1012 | 2.10% | $864K | Equity (common) | United States | USD |
| 15 | Argenx SE | US04016X1019 | 2.07% | $855K | Equity (common) | Netherlands | USD |
| 16 | Vaxcyte Inc | US92243G1085 | 2.06% | $849K | Equity (common) | United States | USD |
| 17 | McKesson Corp | US58155Q1031 | 2.02% | $834K | Equity (common) | United States | USD |
| 18 | Legend Biotech Corp | US52490G1022 | 1.91% | $787K | Equity (common) | Cayman Islands | USD |
| 19 | Danaher Corp | US2358511028 | 1.73% | $711K | Equity (common) | United States | USD |
| 20 | Guardant Health Inc | US40131M1099 | 1.54% | $636K | Equity (common) | United States | USD |
| 21 | Novo Nordisk A/S | US6701002056 | 1.46% | $602K | Equity (common) | Denmark | USD |
| 22 | IDEXX Laboratories Inc | US45168D1046 | 1.40% | $578K | Equity (common) | United States | USD |
| 23 | UnitedHealth Group Inc | US91324P1021 | 1.39% | $573K | Equity (common) | United States | USD |
| 24 | PTC Therapeutics Inc | US69366J2006 | 1.31% | $538K | Equity (common) | United States | USD |
| 25 | Vertex Pharmaceuticals Inc | US92532F1003 | 1.22% | $502K | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.61% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 76.66% | |
| Denmark | 15.07% | |
| Netherlands | 2.59% | |
| France | 2.53% | |
| Cayman Islands | 1.91% | |
| Canada | 0.51% | |
| Switzerland | 0.33% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 99.61% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 78.76% | |
| Industrials | 2.89% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.0750
- 12-month yield
- 0.23%
- Frequency
- Yearly
- Latest ex-date
- 19 Dec 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.0750) ÷ latest price ($32.58) × 100 = 0.23%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (3 payments)
| Ex-date | Amount per unit |
|---|---|
| 19 Dec 2025 | $0.0750 |
| 20 Dec 2024 | $0.1350 |
| 21 Dec 2023 | $0.4610 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000077996) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- MEDI and VT Vanguard Total World Stock Index ETF
- MEDI and SMH VanEck Semiconductor ETF
- MEDI and SOXX iShares PHLX SOX Semiconductor Sector Index Fund
- MEDI and CGDV Capital Group Dividend Value ETF